130 related articles for article (PubMed ID: 3579247)
1. [Sensitivity of clinical bacterial strains to dioxidine in vitro under aerobic and anaerobic conditions].
Ponomareva TR
Antibiot Med Biotekhnol; 1987 Mar; 32(3):199-202. PubMed ID: 3579247
[TBL] [Abstract][Full Text] [Related]
2. [Changes in sensitivity of clinical strains of bacteria to dioxidine from 1984 to 1988].
Bol'shakov LV
Antibiot Khimioter; 1990 Sep; 35(9):17-9. PubMed ID: 2275583
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of dioxidine under aero- and anaerobic conditions].
Bol'shakov LV
Antibiot Med Biotekhnol; 1986 Oct; 31(10):760-4. PubMed ID: 3789685
[TBL] [Abstract][Full Text] [Related]
4. [Experimental criteria for interpretation of bacterial sensitivity to dioxidine determined by diffusion from the disks].
Ponomareva TR; Malakhova VA
Antibiot Khimioter; 1990 Jul; 35(7):23-5. PubMed ID: 2126705
[TBL] [Abstract][Full Text] [Related]
5. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
7. [Bacteria isolated from perforation peritonitis and their antimicrobial susceptibilities].
Shinagawa N; Tanaka K; Mikamo H; Watanabe K; Takeyama H; Yokoyama T; Takesue Y; Taniguchi M
Jpn J Antibiot; 2007 Aug; 60(4):206-20. PubMed ID: 18018418
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of sitafloxacin against clinical isolates in 2009].
Amano A; Matsuzaki K; Kishi N; Saika T; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Kanda Y; Shiozawa T
Jpn J Antibiot; 2010 Dec; 63(6):411-30. PubMed ID: 21425595
[TBL] [Abstract][Full Text] [Related]
9. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
10. EVALUATION OF THE TEA TREE OIL ACTIVITY TO ANAEROBIC BACTERIA--IN VITRO STUDY.
Ziółkowska-Klinkosz M; Kedzia A; Meissner HO; Kedzia AW
Acta Pol Pharm; 2016; 73(2):389-94. PubMed ID: 27180431
[TBL] [Abstract][Full Text] [Related]
11. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between april 2003 and march 2004].
Shinagawa N; Fuchimoto S; Sueda T; Hiyama E; Takesue Y; Murakami Y; Ooge H; Uemura K; Mizuno I; Tsumura H; Hirata K; Katsuramaki T; Mizukuchi T; Ushijima Y; Ushida T; Aikawa N; Yo K; Takayama T; Sato T; Kato K; Yura J; Manabe T; Takeyama H; Wakasugi T; Taniguchi M; Yokoyama T; Takeuchi H; Yasui Y; Mashita K; Ikeda S; Yasunami Y; Ryu S; Ishikawa S; Mizuno A; Kubo S; Suehiro S; Fujimoto M; Higaki K; Tanimura H; Taniguchi K; Tsuji T; Ohnishi H; Yamaue H; Kawai M; Tanaka N; Iwagaki H; Kimura H
Jpn J Antibiot; 2007 Apr; 60(2):59-97. PubMed ID: 17612256
[TBL] [Abstract][Full Text] [Related]
12. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009].
Shinagawa N; Hasegawa M; Hirata K; Furuhata T; Mizukuchi T; Osanai H; Yanai Y; Hata F; Sasaki K; Someya T; Harada K; Oono K; Tokita S; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Oshima H; Maeda H; Mukaiya M; Kihara C; Kosho W; Hoshikawa T; Kimura H; Ushijima Y; Yae-Hoon Y; Aikawa N; Abe S; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Fukui T; Mashita K; Ishikawa S; Mizuno A; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Tsumura H; Yokoyama T; Takeuchi H; Tanakaya K; Yasunami Y; Ryu S
Jpn J Antibiot; 2010 Apr; 63(2):105-70. PubMed ID: 20919496
[TBL] [Abstract][Full Text] [Related]
13. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
[No Abstract] [Full Text] [Related]
15. [Comparative sensitivity of clinical strains of gram-positive and gram-negative microorganisms to antibacterial antibiotics].
Nekhorosheva AG; Khantimer EI
Antibiot Med Biotekhnol; 1986 Apr; 31(4):291-4. PubMed ID: 3717927
[TBL] [Abstract][Full Text] [Related]
16. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2010 and March 2011].
Shinagawa N; Taniguchi M; Hirata K; Furuhata T; Fukuhara K; Mizugucwi T; Osanai H; Yanai Y; Hata F; Kihara C; Sasaki K; Oono K; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Watabe K; Kobayashi Y; Yamaue H; Hirono S; Takesue Y; Fujiwara T; Shinoura S; Kimura H; Hoshikawa T; Oshima H; Aikawa N; Sasaki J; Suzuki M; Sekine K; Abe S; Takeyama H; Wakasugi T; Mashita K; Tanaka M; Mizuno A; Ishikawa M; Iwai A; Saito T; Muramoto M; Kubo S; Lee S; Fukuhara K; Iwagaki H; Tokunaga N; Sueda T; Hiyama E; Murakami Y; Ohge H; Uemura K; Tsumura H; Kanehiro T; Takeuchi H; Tanakaya K; Iwasaki M
Jpn J Antibiot; 2014 Oct; 67(5):293-334. PubMed ID: 25549405
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of cefatrizine on clinical isolates of gram-positive, gram-negative cocci, Haemophilus, and Enterobacteriaceae.
Boisivon A; Perenet F; Guiomar C
J Chemother; 1989 Jul; 1(4 Suppl):304-5. PubMed ID: 16312412
[No Abstract] [Full Text] [Related]
19. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
[TBL] [Abstract][Full Text] [Related]
20. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
